CJR-X: An Orthopedic Surgeon’s Playbook
If you perform Medicare joint replacements, CJR-X belongs in your 2027 planning. CMS has finalized the model as mandatory and nationwide, effective January 1, 2028. Episode accountability is back, and this time, no market gets a geographic carve-out. Here's how the model works, where surgeons fit, and the four moves to make before it takes effect.
August 13, 2026
5 min. read
If you perform Medicare joint replacements, CJR-X needs to be part of your 2027 planning process. CMS has finalized the Comprehensive Care for Joint Replacement Expanded model in the FY 2027 IPPS rule. It will be mandatory, nationwide, and effective January 1, 2028. Episode accountability for lower-extremity joint replacement is coming back, and this time there’s no geographic carve-out protecting any market.
What CJR-X actually is
CJR-X covers hip, knee, and ankle replacement procedures in both inpatient and outpatient hospital settings, with the hospital accountable for the full 90-day episode. Episodes are triggered by inpatient MS-DRGs 469, 470, 521, and 522, and by outpatient HCPCS 27130 (hip) and 27447 (knee); outpatient ankle replacement is excluded for now. The design borrows the risk-adjustment sophistication of the TEAM model but keeps the 90-day episode window of the original CJR.
Two features affect the financial equation: a 2 percent discount factor applied to the target price, down from 3 percent in the original model, representing Medicare’s share of expected savings. And unlike TEAM, CJR-X does not phase in downside risk; every participating hospital is proposed to be at two-sided risk from the first performance year, with gains and losses capped at 20 percent for most hospitals and 5 percent for rural, Medicare-dependent, sole community, and safety-net hospitals.
Where the surgeon fits
For private-practice orthopedic surgeons, the model lands differently than it does for employed physicians. The hospital carries the financial risk as the accountable entity, but that does not make surgeons bystanders. Physicians own the relationship with the patient before surgery, and they prescribe the post-acute pathway that drives a large share of episode cost. That leverage makes orthopedic surgeons the partners hospitals need, and it positions them for gainsharing arrangements that offer revenue opportunities.
CJR-X would allow hospitals to enter into sharing arrangements with collaborators, including physicians, to distribute reconciliation payments and, in certain structures, share repayment risk. These arrangements must be performance-based, documented, compliant with applicable fraud-and-abuse waivers, and never tied to referral volume. The surgeons who understand episode economics and come to the table with a care-coordination plan will shape those arrangements.
Quality is the multiplier
CJR-X ties revenue to quality through a Composite Quality Score built from five measures. The score determines both a hospital’s eligibility for a reconciliation payment and the effective discount factor, so stronger quality raises the target the hospital is measured against and improves its financial position.1 The five measures are: the risk-standardized complication rate after hip and knee replacement, hospital visits within seven days of outpatient surgery, the HCAHPS and OAS CAHPS patient-experience surveys, and the THA/TKA patient-reported outcome measure.2
Surgeons’ focus should follow how the score is built. Two of the five measures track complications and early hospital visits, and CMS designed the model to reward avoidance of costly, harmful events. That is good news for surgeons, because keeping complication and readmission rates low is the lever they most directly control.
The financial picture
The original CJR model produced an estimated $112.7 million in net Medicare savings across its final two performance years while maintaining quality of care. Most of that savings came from post-acute care, primarily reduced skilled nursing facility use and fewer readmissions. That is the pool a well-run practice helps its hospital partner capture, a share of which can flow back through gainsharing.
Post-acute care is where the opportunity lives
Most episode cost, and most of the savings opportunity, sits in post-acute care. A patient discharged to a skilled nursing facility costs far more than one who recovers at home with outpatient or home-based physical therapy, and for appropriately selected patients, the home pathway is well supported clinically.
The goal is not to cut rehabilitation. Appropriate, well-dosed therapy produces the functional outcomes that drive the quality scores CJR-X rewards, and reducing rehabilitation intensity to chase short-term savings shows up fast in the patient-reported outcome measure.
Smarter post-acute stewardship means evidence-based criteria for who needs institutional care versus who can safely recover at home, strong outpatient therapy partners who can manage higher-acuity patients, and clear communication so everyone is working to defined standards.
Four steps to take before CJR-X takes effect
Audit episode cost data. Request 90-day episode claims data from your hospital partner and see where your costs fall against regional benchmarks. This is the foundation of any gainsharing negotiation.
Map post-acute referral patterns. Know which skilled nursing facilities, home health agencies, and outpatient therapy providers your patients flow to, what they cost, and what their outcomes look like.
Build a therapy partnership strategy. Identify high-performing outpatient therapy partners and start the conversation now about pathways, outcome tracking, and communication. A partner who documents functional outcomes and flags complications early is a measurable asset to episode performance.
Engage hospital finance and quality teams. If your hospital has not started modeling CJR-X, push that conversation. You want a seat at the table when gainsharing is designed, not a term sheet after the model goes live.
CJR-X is now the default structure for Medicare joint replacements. For private-practice orthopedic surgeons, the window to get ahead of this model is narrow. The surgeons who use it well will shape how it works in their markets and create new opportunities for expansion and growth. Jump in now and let us help you succeed in the model.
References
Meet the Author
